01 / Contracting Office Profile
Nac Pharmaceuticals (36E797) Federal Contracts and Spending
Office code 36E797
Nac Pharmaceuticals (36E797) is a federal contracting office within VETERANS AFFAIRS, DEPARTMENT OF. This profile shows the office’s purchasing scale, incumbent vendors, market classifications, competition, and recent contract activity.
02 / Market Size
Nac Pharmaceuticals (36E797) contract market at a glance
Net obligations, purchasing activity, and supplier participation measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, Nac Pharmaceuticals (36E797) accounts for 0.0% of its parent agency’s net contract obligations. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
Nac Pharmaceuticals (36E797) contract spending by year
Annual net obligations for FY 2019–FY 2025 show whether the office’s recorded contract market is growing or contracting. Actions and vendors indicate whether that change reflects broader purchasing activity or a smaller number of large transactions.
Total obligations$9.18M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Vendors | Change |
|---|---|---|---|---|
| FY 2025 | $9.18M | 61 | 3 | −13.7% |
| FY 2024 | $10.63M | 86 | 3 | +8.2% |
| FY 2023 | $9.83M | 82 | 3 | −3.3% |
| FY 2022 | $10.16M | 63 | 3 | −10.2% |
| FY 2021 | $11.32M | 88 | 4 | +44.0% |
| FY 2020 | $7.86M | 57 | 5 | −25.6% |
| FY 2019 | $10.57M | 69 | 5 | — |
04 / Buying Hierarchy
Where does Nac Pharmaceuticals (36E797) sit in the federal buying structure?
The office executes procurement within a contracting agency, which belongs to a federal department. Follow either profile to compare this office with the broader organizations directing and funding its activity.
| Organization level | Organization | Code | Explore |
|---|---|---|---|
| Contracting agency | VETERANS AFFAIRS, DEPARTMENT OF | 3600 | View agency profile |
| Federal department | VETERANS AFFAIRS, DEPARTMENT OF | 3600 | View department profile |
05 / Top NAICS Industries
Which industries receive the most Nac Pharmaceuticals (36E797) contract spending?
NAICS industries ranked by recorded obligations show where this office’s contract demand is concentrated and how many actions and vendors participate in each market.
06 / Top Product and Service Codes
What products and services does Nac Pharmaceuticals (36E797) buy?
Product and Service Codes ranked by recorded obligations show the specific categories purchased by this office.
07 / Top Vendors
Which contractors receive the most Nac Pharmaceuticals (36E797) obligations?
Vendors are ranked by recorded obligations to show the office’s leading incumbents, their share of spending, purchasing activity, and primary NAICS and PSC markets.
| Vendor | Obligations | Awards / actions | Share | Primary NAICS / PSC |
|---|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | $37.14M | 304 | 53.4% | NAICS 325412 · PSC 6505 |
| APHENA PHARMA SOLUTIONS - TENNESSEE, LLC. | $15.66M | 59 | 22.5% | NAICS 493110 · PSC 6505 |
| KREMERS URBAN PHARMACEUTICALS INC. | $11.00M | 31 | 15.8% | NAICS 325412 · PSC 6505 |
| EXELAN PHARMACEUTICALS INC. | $3.99M | 56 | 5.7% | NAICS 325412 · PSC 6505 |
| MYLAN PHARMACEUTICALS INC. | $1.43M | 52 | 2.1% | NAICS 325412 · PSC 6505 |
| AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | $347.1K | 4 | 0.5% | NAICS 325412 · PSC 6505 |
08 / Buying Pattern
How does Nac Pharmaceuticals (36E797) award contract work?
Competition, small-business participation, set-asides, transaction size, and action types provide a compact view of how the office structures its recorded contract activity.
Competition rate 100.0%
Small-business share 0.0%
Set-aside share 0.0%
Average action value $137.5K
Largest recorded action $1.14M
09 / Recent Contract Awards
What did Nac Pharmaceuticals (36E797) award most recently in FY 2019–FY 2025?
The latest recorded contract actions inside this profile’s closed fiscal-year window connect award activity with the vendors, markets, agencies, and offices shown above.
| Award / PIID | Vendor | Signed date | Obligation | NAICS | PSC | Contracting agency / office |
|---|---|---|---|---|---|---|
| 36E79725N0033 | APHENA PHARMA SOLUTIONS - TENNESSEE, LLC | Aug 28, 2025 | -$329.1K | 493110 | Q999 | VETERANS AFFAIRS, DEPARTMENT OF NAC PHARMACEUTICALS (36E797) |
| 36E79725N0034 | GOLDEN STATE MEDICAL SUPPLY, INC. | Aug 5, 2025 | $49.2K | 325412 | 6505 | VETERANS AFFAIRS, DEPARTMENT OF NAC PHARMACEUTICALS (36E797) |
| 36E79725N0035 | GOLDEN STATE MEDICAL SUPPLY, INC. | Aug 5, 2025 | $3.3K | 325412 | 6505 | VETERANS AFFAIRS, DEPARTMENT OF NAC PHARMACEUTICALS (36E797) |
| 36E79725N0031 | GOLDEN STATE MEDICAL SUPPLY, INC. | Jul 9, 2025 | -$21.0K | 325412 | 6505 | VETERANS AFFAIRS, DEPARTMENT OF NAC PHARMACEUTICALS (36E797) |
| 36E79725N0033 | APHENA PHARMA SOLUTIONS - TENNESSEE, LLC | Jul 7, 2025 | $600.0K | 493110 | Q999 | VETERANS AFFAIRS, DEPARTMENT OF NAC PHARMACEUTICALS (36E797) |
| 36E79725N0032 | GOLDEN STATE MEDICAL SUPPLY, INC. | Jul 2, 2025 | $208.0K | 325412 | 6505 | VETERANS AFFAIRS, DEPARTMENT OF NAC PHARMACEUTICALS (36E797) |
10 / Interpreting the Profile
What does this contract market mean for a supplier?
This profile combines spending scale, the buying hierarchy, incumbent vendors, market classifications, and competition indicators. Read them together before deciding whether Nac Pharmaceuticals (36E797) represents an addressable market for your company.
Read spending in context
$69.57M in recorded obligations describes historical market scale. Compare it with 506 contract actions and an average action value of $137.5K to understand purchasing frequency and transaction size.
Follow the actual buyers
This office sits within VETERANS AFFAIRS, DEPARTMENT OF and VETERANS AFFAIRS, DEPARTMENT OF. Use that hierarchy to understand who directs its mission and how its purchasing compares with the broader organization.
Do not confuse scale with access
A large historical total does not mean the same amount is currently open for competition. Use the 100.0% competition rate, set-aside share, recent awards, and current opportunities to estimate what may actually be addressable.
Test market fit and incumbency
Compare leading vendors with NAICS 325412 and PSC 6505. Supplier concentration and competition reveal whether demand aligns with your capabilities and how difficult displacement may be.